Abiraterone
The serum concentration of Carvedilol can be increased when it is combined with Abiraterone.
Acebutolol
Acebutolol may increase the orthostatic hypotensive activities of Carvedilol.
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Carvedilol.
Advertisement
Acemetacin
The therapeutic efficacy of Carvedilol can be decreased when used in combination with Acemetacin.
Acepromazine
Carvedilol may increase the antihypertensive activities of Acepromazine.
Aceprometazine
Aceprometazine may increase the hypotensive activities of Carvedilol.
Advertisement
Acetohexamide
Carvedilol may increase the hypoglycemic activities of Acetohexamide.
Acetyl salicylate
Acetylsalicylic acid may decrease the antihypertensive activities of Carvedilol.
Acetyl Sulfisoxazole
The serum concentration of Carvedilol can be increased when it is combined with Acetyl sulfisoxazole.
Advertisement
Acetylcholine
The risk or severity of adverse effects can be increased when Carvedilol is combined with Acetylcholine.
Acetylcholine Chloride
The risk or severity of adverse effects can be increased when Carvedilol is combined with Acetylcholine.
Acetyldigitoxin
Carvedilol may increase the bradycardic activities of Acetyldigitoxin.
Adapalene
Adapalene may decrease the antihypertensive activities of Carvedilol.
Adrafinil
Carvedilol may decrease the vasoconstricting activities of Adrafinil.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Carvedilol.
Albuterol
Carvedilol may decrease the vasoconstricting activities of Salbutamol.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carvedilol.
Alfentanil
Alfentanil may increase the bradycardic activities of Carvedilol.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Carvedilol.
Aliskiren
Carvedilol may increase the hypotensive activities of Aliskiren.
Alminoprofen
Alminoprofen may decrease the antihypertensive activities of Carvedilol.
Alprenolol
Alprenolol may increase the orthostatic hypotensive activities of Carvedilol.
Ambenonium
Ambenonium may increase the bradycardic activities of Carvedilol.
Ambrisentan
Carvedilol may increase the hypotensive activities of Ambrisentan.
Amifostine
Carvedilol may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Carvedilol may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Carvedilol.
Amiodarone
The serum concentration of Carvedilol can be increased when it is combined with Amiodarone.
Amitriptyline
Carvedilol may increase the antihypertensive activities of Amitriptyline.
Amlodipine
Amlodipine may increase the hypotensive activities of Carvedilol.
Amobarbital
The serum concentration of Carvedilol can be decreased when it is combined with Amobarbital.
Amodiaquine
The metabolism of Carvedilol can be decreased when combined with Amodiaquine.
Amoxapine
Carvedilol may increase the antihypertensive activities of Amoxapine.
Amphetamine
Amphetamine may increase the hypotensive activities of Carvedilol.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Carvedilol.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Carvedilol.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Carvedilol is combined with Amyl Nitrite.
Antipyrine
Antipyrine may decrease the antihypertensive activities of Carvedilol.
Apalutamide
The serum concentration of Carvedilol can be decreased when it is combined with Apalutamide.
Apazone
Azapropazone may decrease the antihypertensive activities of Carvedilol.
Apomorphine
Apomorphine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Apraclonidine
Carvedilol may decrease the vasoconstricting activities of Apraclonidine.
Apremilast
Apremilast may decrease the antihypertensive activities of Carvedilol.
Aprepitant
The serum concentration of Carvedilol can be increased when it is combined with Aprepitant.
Arbutamine
Carvedilol may decrease the vasoconstricting activities of Arbutamine.
Arformoterol
Carvedilol may decrease the vasoconstricting activities of Arformoterol.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Carvedilol.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Carvedilol.
Artemether
The metabolism of Carvedilol can be decreased when combined with Artemether.
Asenapine
Carvedilol may increase the antihypertensive activities of Asenapine.
Aspirin
Acetylsalicylic acid may decrease the antihypertensive activities of Carvedilol.
Atazanavir
The metabolism of Carvedilol can be decreased when combined with Atazanavir.
Atenolol
Atenolol may increase the orthostatic hypotensive activities of Carvedilol.
Atomoxetine
The metabolism of Carvedilol can be decreased when combined with Atomoxetine.
Avanafil
Avanafil may increase the hypotensive activities of Carvedilol.
Azelastine
Azelastine may decrease the antihypertensive activities of Carvedilol.
Azilsartan
The risk or severity of adverse effects can be increased when Carvedilol is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Carvedilol is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Carvedilol is combined with Azilsartan medoxomil.
Azithromycin
The metabolism of Carvedilol can be decreased when combined with Azithromycin.
Balsalazide
Balsalazide may decrease the antihypertensive activities of Carvedilol.
Bambuterol
Carvedilol may decrease the vasoconstricting activities of Bambuterol.
Barbexaclone
The serum concentration of Carvedilol can be decreased when it is combined with Barbexaclone.
Barbital
The serum concentration of Carvedilol can be decreased when it is combined with Barbital.
Benazepril
Benazepril may increase the hypotensive activities of Carvedilol.
Bencyclane
The risk or severity of hypotension can be increased when Carvedilol is combined with Bencyclane.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Carvedilol.
Benzphetamine
Benzphetamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Benzydamine
Benzydamine may decrease the antihypertensive activities of Carvedilol.
Bepridil
Carvedilol may increase the hypotensive activities of Bepridil.
Beractant
Carvedilol may increase the bradycardic activities of Beractant.
Betaxolol
Betaxolol may increase the orthostatic hypotensive activities of Carvedilol.
Bethanechol
The risk or severity of adverse effects can be increased when Carvedilol is combined with Bethanechol.
Bethanidine
Bethanidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Bimatoprost
Bimatoprost may increase the hypotensive activities of Carvedilol.
Bioallethrin
The risk or severity of hypotension can be increased when Carvedilol is combined with Bioallethrin.
Bisoprolol
Bisoprolol may increase the orthostatic hypotensive activities of Carvedilol.
Bitolterol
Carvedilol may decrease the vasoconstricting activities of Bitolterol.
Bitolterol Mesylate
Carvedilol may decrease the vasoconstricting activities of Bitolterol.
Boceprevir
The metabolism of Carvedilol can be decreased when combined with Boceprevir.
Bopindolol
Bopindolol may increase the orthostatic hypotensive activities of Carvedilol.
Bortezomib
The metabolism of Carvedilol can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Carvedilol can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Carvedilol can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Carvedilol.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Carvedilol.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Carvedilol.
Bretylium
Bretylium may increase the bradycardic activities of Carvedilol.
Brexpiprazole
Carvedilol may increase the antihypertensive activities of Brexpiprazole.
Brimonidine
Brimonidine may increase the antihypertensive activities of Carvedilol.
Bromfenac
Bromfenac may decrease the antihypertensive activities of Carvedilol.
Bromocriptine
Bromocriptine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Bufexamac
Bufexamac may decrease the antihypertensive activities of Carvedilol.
Bumetanide
The risk or severity of adverse effects can be increased when Bumetanide is combined with Carvedilol.
Bunazosin
Carvedilol may increase the antihypertensive activities of Bunazosin.
Bupivacaine
The serum concentration of Bupivacaine can be increased when it is combined with Carvedilol.
Bupranolol
Bupranolol may increase the orthostatic hypotensive activities of Carvedilol.
Bupropion
The metabolism of Carvedilol can be decreased when combined with Bupropion.
Cabergoline
Carvedilol may increase the vasoconstricting activities of Cabergoline.
Cafedrine
Carvedilol may increase the hypotensive activities of Cafedrine.
Caffeine
The metabolism of Carvedilol can be decreased when combined with Caffeine.
Calfactant
Carvedilol may increase the bradycardic activities of Calfactant.
Canagliflozin
The risk or severity of adverse effects can be increased when Carvedilol is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Carvedilol is combined with Canagliflozin.
Candesartan
Carvedilol may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Candesartan cilexetil may increase the hypotensive activities of Carvedilol.
Capecitabine
The serum concentration of Carvedilol can be increased when it is combined with Capecitabine.
Captopril
Carvedilol may increase the hypotensive activities of Captopril.
Carbachol
The risk or severity of adverse effects can be increased when Carvedilol is combined with Carbachol.
Carbamazepine
The metabolism of Carvedilol can be increased when combined with Carbamazepine.
Carprofen
Carprofen may decrease the antihypertensive activities of Carvedilol.
Carteolol
Carteolol may increase the orthostatic hypotensive activities of Carvedilol.
Celecoxib
The metabolism of Carvedilol can be decreased when combined with Celecoxib.
Celiprolol
Celiprolol may increase the orthostatic hypotensive activities of Carvedilol.
Ceritinib
Carvedilol may increase the bradycardic activities of Ceritinib.
Cevimeline
The risk or severity of adverse effects can be increased when Carvedilol is combined with Cevimeline.
Chloroquine
The metabolism of Carvedilol can be decreased when combined with Chloroquine.
Chlorothiazide
Chlorothiazide may increase the hypotensive activities of Carvedilol.
Chlorpromazine
Carvedilol may increase the antihypertensive activities of Chlorpromazine.
Chlorpropamide
Carvedilol may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Carvedilol.
Cholecalciferol
The serum concentration of Carvedilol can be increased when it is combined with Cholecalciferol.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may decrease the antihypertensive activities of Carvedilol.
Cicletanine
Carvedilol may increase the hypotensive activities of Cicletanine.
Cilazapril
Carvedilol may increase the hypotensive activities of Cilazapril.
Cimetidine
The serum concentration of Carvedilol can be increased when it is combined with Cimetidine.
Cinacalcet
The metabolism of Carvedilol can be decreased when combined with Cinacalcet.
Cinnarizine
The risk or severity of hypotension can be increased when Carvedilol is combined with Cinnarizine.
Citalopram
The metabolism of Carvedilol can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Carvedilol can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Carvedilol can be decreased when combined with Clemastine.
Clenbuterol
Carvedilol may decrease the vasoconstricting activities of Clenbuterol.
Clevidipine
The risk or severity of hypotension can be increased when Carvedilol is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of hypotension can be increased when Carvedilol is combined with Clevidipine.
Clobazam
The metabolism of Carvedilol can be decreased when combined with Clobazam.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Carvedilol.
Clomipramine
The metabolism of Carvedilol can be decreased when combined with Clomipramine.
Clonidine
Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Clonixin
Clonixin may decrease the antihypertensive activities of Carvedilol.
Clotrimazole
The serum concentration of Carvedilol can be increased when it is combined with Clotrimazole.
Clozapine
Carvedilol may increase the antihypertensive activities of Clozapine.
Cobicistat
The serum concentration of Carvedilol can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Carvedilol can be decreased when combined with Cocaine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Carvedilol.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Carvedilol.
Crisaborole
The serum concentration of Carvedilol can be increased when it is combined with Crisaborole.
Crizotinib
The metabolism of Carvedilol can be decreased when combined with Crizotinib.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Carvedilol.
Curcumin
The serum concentration of Carvedilol can be increased when it is combined with Curcumin.
Cyclandelate
The risk or severity of hypotension can be increased when Carvedilol is combined with Cyclandelate.
Cyclopenthiazide
Carvedilol may increase the hypotensive activities of Cyclopenthiazide.
Cyclosporine
The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Carvedilol.
Cyproterone Acetate
The serum concentration of Carvedilol can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Carvedilol.
Dabrafenib
The serum concentration of Carvedilol can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The risk or severity of adverse effects can be increased when Carvedilol is combined with Dapagliflozin.
Dapiprazole
Carvedilol may increase the antihypertensive activities of Dapiprazole.
Darifenacin
The metabolism of Carvedilol can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Carvedilol can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Carvedilol can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Carvedilol can be increased when it is combined with Dasatinib.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Carvedilol.
Deferasirox
The serum concentration of Carvedilol can be decreased when it is combined with Deferasirox.
Delavirdine
The serum concentration of Carvedilol can be increased when it is combined with Delavirdine.
Demecarium
Demecarium may increase the bradycardic activities of Carvedilol.
Deserpidine
Carvedilol may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Carvedilol.
Desipramine
Desipramine may increase the orthostatic hypotensive activities of Carvedilol.
Deslanoside
Carvedilol may increase the bradycardic activities of Deslanoside.
Desvenlafaxine
The serum concentration of Carvedilol can be increased when it is combined with Desvenlafaxine.
Dexmedetomidine
Dexmedetomidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Dextroamphetamine
Carvedilol may increase the antihypertensive activities of Dextroamphetamine.
Diazoxide
Diazoxide may increase the hypotensive activities of Carvedilol.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Carvedilol is combined with Diclofenamide.
Diclofenac
Diclofenac may decrease the antihypertensive activities of Carvedilol.
Diflunisal
Diflunisal may decrease the antihypertensive activities of Carvedilol.
Digitoxin
Carvedilol may increase the bradycardic activities of Digitoxin.
Digoxin
Digoxin may increase the bradycardic activities of Carvedilol.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Carvedilol.
Dihydroergotamine
Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Diltiazem
The metabolism of Carvedilol can be decreased when combined with Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Carvedilol is combined with Dinutuximab.
Diphenhydramine
The metabolism of Carvedilol can be decreased when combined with Diphenhydramine.
Dipivefrin
Dipivefrin may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Dipyridamole
Dipyridamole may increase the bradycardic activities of Carvedilol.
Dipyrone
Metamizole may decrease the antihypertensive activities of Carvedilol.
Disopyramide
Disopyramide may increase the bradycardic activities of Carvedilol.
Distigmine
Distigmine may increase the bradycardic activities of Carvedilol.
Dobutamine
Carvedilol may decrease the vasoconstricting activities of Dobutamine.
Donepezil
Donepezil may increase the bradycardic activities of Carvedilol.
Dopexamine
Carvedilol may decrease the vasoconstricting activities of Dopexamine.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Carvedilol.
Dothiepin
The serum concentration of Carvedilol can be increased when it is combined with Dosulepin.
Doxazosin
Doxazosin may increase the antihypertensive activities of Carvedilol.
Doxepin
Carvedilol may increase the antihypertensive activities of Doxepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Carvedilol.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Carvedilol.
Doxycycline
The metabolism of Carvedilol can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Carvedilol can be decreased when combined with Doxycycline.
Dronedarone
Dronedarone may increase the bradycardic activities of Carvedilol.
Droperidol
Carvedilol may increase the antihypertensive activities of Droperidol.
Droxicam
Droxicam may decrease the antihypertensive activities of Carvedilol.
Droxidopa
Droxidopa may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Duloxetine
Carvedilol may increase the orthostatic hypotensive activities of Duloxetine.
Echothiophate
Echothiophate may increase the bradycardic activities of Carvedilol.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Carvedilol.
Edrophonium
Edrophonium may increase the bradycardic activities of Carvedilol.
Efavirenz
The serum concentration of Carvedilol can be increased when it is combined with Efavirenz.
Eliglustat
The metabolism of Carvedilol can be decreased when combined with Eliglustat.
Empagliflozin
The risk or severity of adverse effects can be increased when Carvedilol is combined with Empagliflozin.
Enalapril
Enalapril may increase the hypotensive activities of Carvedilol.
Enalaprilat
Carvedilol may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Carvedilol may increase the hypotensive activities of Enalaprilat.
Enzalutamide
The serum concentration of Carvedilol can be decreased when it is combined with Enzalutamide.
Ephedrine
Carvedilol may decrease the vasoconstricting activities of Ephedrine.
Epinastine
Carvedilol may decrease the vasoconstricting activities of Epinastine.
Epinephrine
Carvedilol may increase the antihypertensive activities of Epinephrine.
Eplerenone
The risk or severity of adverse effects can be increased when Eplerenone is combined with Carvedilol.
Epoprostenol
Carvedilol may increase the hypotensive activities of Epoprostenol.
Eprosartan
Eprosartan may increase the hypotensive activities of Carvedilol.
ergoloid mesylates, USP
Carvedilol may increase the vasoconstricting activities of Ergoloid mesylate.
Ergonovine
Carvedilol may increase the vasoconstricting activities of Ergonovine.
Ergotamine
Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Erythromycin
The metabolism of Carvedilol can be decreased when combined with Erythromycin.
Escitalopram
Carvedilol may increase the antihypertensive activities of Escitalopram.
Esmolol
Esmolol may increase the orthostatic hypotensive activities of Carvedilol.
Etanercept
Etanercept may decrease the antihypertensive activities of Carvedilol.
Ethacrynate
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Carvedilol.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Carvedilol.
Ethosuximide
The risk or severity of hypotension can be increased when Carvedilol is combined with Ethosuximide.
Etilefrine
Carvedilol may decrease the vasoconstricting activities of Etilefrine.
Etodolac
Etodolac may decrease the antihypertensive activities of Carvedilol.
Etofenamate
Etofenamate may decrease the antihypertensive activities of Carvedilol.
Etomidate
Etomidate may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Etoricoxib
Etoricoxib may decrease the antihypertensive activities of Carvedilol.
Etravirine
The serum concentration of Carvedilol can be increased when it is combined with Etravirine.
Evening primrose oil
Evening primrose oil may decrease the antihypertensive activities of Carvedilol.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Carvedilol.
Felbinac
Felbinac may decrease the antihypertensive activities of Carvedilol.
Felodipine
Felodipine may increase the hypotensive activities of Carvedilol.
Fenbufen
Fenbufen may decrease the antihypertensive activities of Carvedilol.
Fendiline
The risk or severity of hypotension can be increased when Carvedilol is combined with Fendiline.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Carvedilol.
Fenoprofen
Fenoprofen may decrease the antihypertensive activities of Carvedilol.
Fenoterol
Carvedilol may decrease the vasoconstricting activities of Fenoterol.
Fentanyl
Fentanyl may increase the bradycardic activities of Carvedilol.
Ferulic Acid
Carvedilol may increase the hypotensive activities of Ferulic acid.
Fingolimod
Carvedilol may increase the bradycardic activities of Fingolimod.
Fish Oils
The risk or severity of hypotension can be increased when Carvedilol is combined with Fish oil.
Floctafenine
The risk or severity of adverse effects can be increased when Carvedilol is combined with Floctafenine.
Floxuridine
The serum concentration of Carvedilol can be increased when it is combined with Floxuridine.
Fluconazole
The serum concentration of Carvedilol can be increased when it is combined with Fluconazole.
Flunarizine
The risk or severity of hypotension can be increased when Carvedilol is combined with Flunarizine.
Fluorouracil
The serum concentration of Carvedilol can be increased when it is combined with Fluorouracil.
Fluoxetine
The metabolism of Carvedilol can be decreased when combined with Fluoxetine.
Flupenthixol
Carvedilol may increase the antihypertensive activities of Flupentixol.
Fluphenazine
Fluphenazine may increase the hypotensive activities of Carvedilol.
Flurbiprofen
Flurbiprofen may decrease the antihypertensive activities of Carvedilol.
Fluspirilene
The risk or severity of hypotension can be increased when Carvedilol is combined with Fluspirilene.
Fluvastatin
The serum concentration of Carvedilol can be increased when it is combined with Fluvastatin.
Fluvoxamine
The serum concentration of Carvedilol can be increased when it is combined with Fluvoxamine.
Formoterol
Carvedilol may decrease the vasoconstricting activities of Formoterol.
Fosamprenavir
The metabolism of Carvedilol can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Carvedilol can be increased when it is combined with Fosaprepitant.
Fosinopril
Fosinopril may increase the hypotensive activities of Carvedilol.
Fosphenytoin
The metabolism of Carvedilol can be increased when combined with Fosphenytoin.
Fostamatinib
Fostamatinib may increase the hypotensive activities of Carvedilol.
Furazolidone
Furazolidone may increase the hypotensive activities of Carvedilol.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Carvedilol.
Fusidate
The serum concentration of Carvedilol can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Carvedilol can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of hypotension can be increased when Carvedilol is combined with Gabapentin.
Galantamine
Galantamine may increase the bradycardic activities of Carvedilol.
Gallamine Triethiodide
Gallamine Triethiodide may increase the bradycardic activities of Carvedilol.
Gallopamil
The risk or severity of hypotension can be increased when Carvedilol is combined with Gallopamil.
Gemfibrozil
The serum concentration of Carvedilol can be increased when it is combined with Gemfibrozil.
Ginkgo biloba extract
Ginkgo biloba may increase the bradycardic activities of Carvedilol.
Glibornuride
Carvedilol may increase the hypoglycemic activities of Glibornuride.
Gliclazide
Carvedilol may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Carvedilol may increase the hypoglycemic activities of Glimepiride.
Glipizide
Carvedilol may increase the hypoglycemic activities of Glipizide.
Gliquidone
Carvedilol may increase the hypoglycemic activities of Gliquidone.
Glyburide
Carvedilol may increase the hypoglycemic activities of Glyburide.
Guanabenz
Guanabenz may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Guanadrel
Guanadrel may increase the hypotensive activities of Carvedilol.
Guanethidine
Carvedilol may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Haloperidol
The metabolism of Carvedilol can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Carvedilol.
Hexobarbital
The serum concentration of Carvedilol can be decreased when it is combined with Hexobarbital.
Hexoprenaline
Carvedilol may decrease the vasoconstricting activities of Hexoprenaline.
Hydralazine
Hydralazine may increase the hypotensive activities of Carvedilol.
Hydrochlorothiazide
Hydrochlorothiazide may increase the hypotensive activities of Carvedilol.
Hydroflumethiazide
Hydroflumethiazide may increase the hypotensive activities of Carvedilol.
Hydroxychloroquine
The metabolism of Carvedilol can be decreased when combined with Hydroxychloroquine.
Hypoxis hemerocallidea root extract
The serum concentration of Carvedilol can be decreased when it is combined with St. John's Wort.
Ibuprofen
Ibuprofen may decrease the antihypertensive activities of Carvedilol.
Icatibant
Icatibant may decrease the antihypertensive activities of Carvedilol.
Idelalisib
The metabolism of Carvedilol can be decreased when combined with Idelalisib.
Iloperidone
Carvedilol may increase the antihypertensive activities of Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Carvedilol.
Imatinib
The metabolism of Carvedilol can be decreased when combined with Imatinib.
Imidapril
Carvedilol may increase the hypotensive activities of Imidapril.
Imipramine
Carvedilol may increase the antihypertensive activities of Imipramine.
Inamrinone
The risk or severity of hypotension can be increased when Carvedilol is combined with Amrinone.
Indacaterol
Carvedilol may decrease the vasoconstricting activities of Indacaterol.
Indapamide
Indapamide may increase the hypotensive activities of Carvedilol.
Indinavir
The serum concentration of Carvedilol can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Carvedilol can be increased when it is combined with Indinavir.
Indobufen
Indobufen may decrease the antihypertensive activities of Carvedilol.
Indomethacin
Indomethacin may decrease the antihypertensive activities of Carvedilol.
Indoramin
Carvedilol may increase the antihypertensive activities of Indoramin.
insulin human, rDNA origin
Carvedilol may increase the hypoglycemic activities of Insulin Human.
Insulin, Pork
Carvedilol may increase the hypoglycemic activities of Insulin Pork.
Insulin, Regular, Pork
Carvedilol may increase the hypoglycemic activities of Insulin Pork.
Iproniazid
Iproniazid may increase the hypotensive activities of Carvedilol.
Irbesartan
The serum concentration of Carvedilol can be increased when it is combined with Irbesartan.
Isavuconazole
The serum concentration of Carvedilol can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Carvedilol can be decreased when combined with Isavuconazonium.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Carvedilol.
Isoetharine
Carvedilol may decrease the vasoconstricting activities of Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Carvedilol.
Isoflurophate
Isoflurophate may increase the bradycardic activities of Carvedilol.
Isometheptene
Carvedilol may decrease the vasoconstricting activities of Isometheptene.
Isoniazid
The metabolism of Carvedilol can be decreased when combined with Isoniazid.
Isoproterenol
Carvedilol may decrease the vasoconstricting activities of Isoprenaline.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Isosorbide Dinitrate is combined with Carvedilol.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Carvedilol.
Isoxsuprine
Carvedilol may decrease the vasoconstricting activities of Isoxsuprine.
Isradipine
The metabolism of Carvedilol can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Carvedilol can be decreased when combined with Itraconazole.
Ivabradine
Carvedilol may increase the bradycardic activities of Ivabradine.
Ivacaftor
The serum concentration of Carvedilol can be increased when it is combined with Ivacaftor.
Kebuzone
Kebuzone may decrease the antihypertensive activities of Carvedilol.
Ketanserin
Ketanserin may increase the hypotensive activities of Carvedilol.
Ketoconazole
The serum concentration of Carvedilol can be increased when it is combined with Ketoconazole.
Ketoprofen
Ketoprofen may decrease the antihypertensive activities of Carvedilol.
Ketorolac
Ketorolac may decrease the antihypertensive activities of Carvedilol.
Labetalol
Labetalol may increase the antihypertensive activities of Carvedilol.
Lacidipine
Carvedilol may increase the hypotensive activities of Lacidipine.
Lacosamide
Carvedilol may increase the atrioventricular blocking (AV block) activities of Lacosamide.
Lamotrigine
The risk or severity of hypotension can be increased when Carvedilol is combined with Lamotrigine.
Lanreotide
Carvedilol may increase the bradycardic activities of Lanreotide.
Latanoprost
Latanoprost may increase the hypotensive activities of Carvedilol.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Carvedilol.
Leflunomide
The serum concentration of Carvedilol can be increased when it is combined with Leflunomide.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Carvedilol.
Levalbuterol
Carvedilol may decrease the vasoconstricting activities of Levosalbutamol.
Levetiracetam
The risk or severity of hypotension can be increased when Carvedilol is combined with Levetiracetam.
Levobetaxolol
Levobetaxolol may increase the orthostatic hypotensive activities of Carvedilol.
Levobunolol
The risk or severity of adverse effects can be increased when Carvedilol is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Carvedilol.
Levodopa
Carvedilol may increase the orthostatic hypotensive activities of Levodopa.
LEVOMENTHOL
The risk or severity of hypotension can be increased when Carvedilol is combined with Menthol.
Levomilnacipran
The serum concentration of Carvedilol can be increased when it is combined with Levomilnacipran.
Levonordefrin
Levonordefrin may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Carvedilol.
Lidocaine
The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.
Limonene, (+)-
(4R)-limonene may decrease the antihypertensive activities of Carvedilol.
Lisdexamfetamine
Carvedilol may increase the antihypertensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Carvedilol may increase the antihypertensive activities of Lisdexamfetamine.
Lisinopril
Lisinopril may increase the hypotensive activities of Carvedilol.
Lisinopril Anhydrous
Lisinopril may increase the hypotensive activities of Carvedilol.
Lobeline
The risk or severity of adverse effects can be increased when Carvedilol is combined with Lobeline.
Lofexidine
Lofexidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Loperamide
The risk or severity of hypotension can be increased when Carvedilol is combined with Loperamide.
Lopinavir
The metabolism of Carvedilol can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Carvedilol can be decreased when combined with Lorcaserin.
Lornoxicam
Lornoxicam may decrease the antihypertensive activities of Carvedilol.
Losartan
The serum concentration of Carvedilol can be increased when it is combined with Losartan.
Lovastatin
The serum concentration of Carvedilol can be increased when it is combined with Lovastatin.
Loxoprofen
Loxoprofen may decrease the antihypertensive activities of Carvedilol.
Lucinactant
Carvedilol may increase the bradycardic activities of Lucinactant.
Luliconazole
The serum concentration of Carvedilol can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Carvedilol can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Carvedilol can be decreased when combined with Lumefantrine.
Macitentan
Carvedilol may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
Magnesium salicylate may decrease the antihypertensive activities of Carvedilol.
Magnesium Sulfate
The risk or severity of hypotension can be increased when Carvedilol is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The risk or severity of hypotension can be increased when Carvedilol is combined with Magnesium sulfate.
Malathion
Malathion may increase the bradycardic activities of Carvedilol.
Manidipine
The serum concentration of Carvedilol can be increased when it is combined with Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Mannitol is combined with Carvedilol.
Masoprocol
Masoprocol may decrease the antihypertensive activities of Carvedilol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Carvedilol.
Meclofenamate
Meclofenamic acid may decrease the antihypertensive activities of Carvedilol.
Meclofenamic Acid
Meclofenamic acid may decrease the antihypertensive activities of Carvedilol.
Mefenamic Acid
Mefenamic acid may decrease the antihypertensive activities of Carvedilol.
Mefloquine
Mefloquine may increase the bradycardic activities of Carvedilol.
Meloxicam
Meloxicam may decrease the antihypertensive activities of Carvedilol.
Memantine
Memantine may increase the bradycardic activities of Carvedilol.
Menthol
The risk or severity of hypotension can be increased when Carvedilol is combined with Menthol.
Mephentermine
Carvedilol may decrease the vasoconstricting activities of Mephentermine.
Mephobarbital
The serum concentration of Carvedilol can be decreased when it is combined with Methylphenobarbital.
Mepindolol
Mepindolol may increase the orthostatic hypotensive activities of Carvedilol.
Mepirodipine
Carvedilol may increase the antihypertensive activities of Barnidipine.
Mepivacaine
The serum concentration of Mepivacaine can be increased when it is combined with Carvedilol.
Mesalamine
Mesalazine may decrease the antihypertensive activities of Carvedilol.
Mesoridazine
Mesoridazine may increase the hypotensive activities of Carvedilol.
Metaproterenol
Carvedilol may decrease the vasoconstricting activities of Orciprenaline.
Metaraminol
Carvedilol may decrease the vasoconstricting activities of Metaraminol.
Methacholine
Carvedilol may increase the bronchoconstrictory activities of Methacholine.
Methadone
The metabolism of Carvedilol can be decreased when combined with Methadone.
Methamphetamine
Methamphetamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Carvedilol.
Methohexital
The serum concentration of Carvedilol can be decreased when it is combined with Methohexital.
Methotrimeprazine
Carvedilol may increase the antihypertensive activities of Methotrimeprazine.
Methoxamine
Carvedilol may decrease the vasoconstricting activities of Methoxamine.
Methsuximide
The risk or severity of hypotension can be increased when Carvedilol is combined with Methsuximide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Carvedilol.
Methyldopa
Methyldopa may increase the atrioventricular blocking (AV block) activities of Carvedilol.
METHYLDOPA ANHYDROUS
Methyldopa may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Methylene blue
Methylene blue may increase the hypotensive activities of Carvedilol.
METHYLEPHEDRINE, DL-
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Methylergonovine
Carvedilol may increase the vasoconstricting activities of Methylergometrine.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Carvedilol.
Metipranolol
Carvedilol may increase the hypotensive activities of Metipranolol.
Metoclopramide
Metoclopramide may increase the bradycardic activities of Carvedilol.
Metolazone
Metolazone may increase the hypotensive activities of Carvedilol.
Metoprolol
Metoprolol may increase the orthostatic hypotensive activities of Carvedilol.
Metyrosine
Carvedilol may increase the hypotensive activities of Metyrosine.
Mexiletine
The metabolism of Carvedilol can be decreased when combined with Mexiletine.
Mibefradil
Carvedilol may increase the hypotensive activities of Mibefradil.
Midodrine
Carvedilol may increase the bradycardic activities of Midodrine.
Midostaurin
The serum concentration of Carvedilol can be increased when it is combined with Midostaurin.
Mifepristone
The serum concentration of Carvedilol can be increased when it is combined with Mifepristone.
Milnacipran
The serum concentration of Carvedilol can be increased when it is combined with Milnacipran.
Minaprine
Minaprine may increase the bradycardic activities of Carvedilol.
Minoxidil
Minoxidil may increase the hypotensive activities of Carvedilol.
Mirabegron
The metabolism of Carvedilol can be decreased when combined with Mirabegron.
Mitotane
The serum concentration of Carvedilol can be decreased when it is combined with Mitotane.
Moclobemide
Moclobemide may increase the hypotensive activities of Carvedilol.
Moexipril
Moexipril may increase the hypotensive activities of Carvedilol.
Molsidomine
Molsidomine may increase the hypotensive activities of Carvedilol.
Moricizine
Moricizine may increase the hypotensive activities of Carvedilol.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Carvedilol.
Moxonidine
Moxonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
MYCOPHENOLATE
Mycophenolic acid may decrease the antihypertensive activities of Carvedilol.
Mycophenolate Mofetil
Mycophenolate mofetil may decrease the antihypertensive activities of Carvedilol.
Mycophenolic Acid
Mycophenolic acid may decrease the antihypertensive activities of Carvedilol.
N-methylephedrine
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Nabilone
The serum concentration of Carvedilol can be increased when it is combined with Nabilone.
Nabumetone
Nabumetone may decrease the antihypertensive activities of Carvedilol.
Nadolol
Nadolol may increase the orthostatic hypotensive activities of Carvedilol.
Naftifine
Naftifine may decrease the antihypertensive activities of Carvedilol.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Carvedilol.
Naphazoline
Naphazoline may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Naproxen
Naproxen may decrease the antihypertensive activities of Carvedilol.
Nebivolol
Nebivolol may increase the orthostatic hypotensive activities of Carvedilol.
Nefazodone
Carvedilol may increase the antihypertensive activities of Nefazodone.
Nelfinavir
The metabolism of Carvedilol can be decreased when combined with Nelfinavir.
Neostigmine
Neostigmine may increase the bradycardic activities of Carvedilol.
Nepafenac
Nepafenac may decrease the antihypertensive activities of Carvedilol.
Nesiritide
The risk or severity of adverse effects can be increased when Carvedilol is combined with Nesiritide.
Netupitant
The serum concentration of Carvedilol can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Carvedilol can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the hypotensive activities of Carvedilol.
Nicardipine
Nicardipine may increase the hypotensive activities of Carvedilol.
Nicergoline
Carvedilol may increase the antihypertensive activities of Nicergoline.
Nicorandil
Nicorandil may increase the hypotensive activities of Carvedilol.
Nicotine
The metabolism of Carvedilol can be decreased when combined with Nicotine.
Nicotine Polacrilex
The metabolism of Carvedilol can be decreased when combined with Nicotine.
Nifedipine
The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Carvedilol.
Niflumic Acid
Niflumic Acid may decrease the antihypertensive activities of Carvedilol.
Nilotinib
The metabolism of Carvedilol can be decreased when combined with Nilotinib.
Nilvadipine
Carvedilol may increase the hypotensive activities of Nilvadipine.
Nimesulide
The risk or severity of hypotension can be increased when Carvedilol is combined with Nimesulide.
Nimodipine
Nimodipine may increase the hypotensive activities of Carvedilol.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Carvedilol.
Nitrendipine
Nitrendipine may increase the hypotensive activities of Carvedilol.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Carvedilol.
Nitroglycerin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Carvedilol.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Carvedilol.
Norepinephrine
Norepinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Nortriptyline
Carvedilol may increase the antihypertensive activities of Nortriptyline.
Nylidrin
Carvedilol may decrease the vasoconstricting activities of Nylidrin.
O-PHENANTHROLINE
1,10-Phenanthroline may increase the bradycardic activities of Carvedilol.
Obinutuzumab
Carvedilol may increase the hypotensive activities of Obinutuzumab.
Octreotide
Octreotide may increase the bradycardic activities of Carvedilol.
Octylonium
The risk or severity of hypotension can be increased when Carvedilol is combined with Otilonium.
Oenothera biennis seed extract
Evening primrose oil may decrease the antihypertensive activities of Carvedilol.
Olanzapine
Carvedilol may increase the antihypertensive activities of Olanzapine.
Olaparib
The metabolism of Carvedilol can be decreased when combined with Olaparib.
Olmesartan
Olmesartan may increase the hypotensive activities of Carvedilol.
Olodaterol
Carvedilol may decrease the vasoconstricting activities of Olodaterol.
Olopatadine
Olopatadine may decrease the antihypertensive activities of Carvedilol.
Olsalazine
Olsalazine may decrease the antihypertensive activities of Carvedilol.
Omeprazole
The serum concentration of Carvedilol can be increased when it is combined with Omeprazole.
Osimertinib
The serum concentration of Carvedilol can be increased when it is combined with Osimertinib.
Ouabain
Carvedilol may increase the bradycardic activities of Ouabain.
Ovine Digoxin Immune Fab
Carvedilol may increase the bradycardic activities of Digoxin Immune Fab (Ovine).
Oxaprozin
Oxaprozin may decrease the antihypertensive activities of Carvedilol.
Oxprenolol
Oxprenolol may increase the orthostatic hypotensive activities of Carvedilol.
Oxymetazoline
Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Oxyphenbutazone
Oxyphenbutazone may decrease the antihypertensive activities of Carvedilol.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Carvedilol.
Palbociclib
The serum concentration of Carvedilol can be increased when it is combined with Palbociclib.
Paliperidone
Carvedilol may increase the antihypertensive activities of Paliperidone.
Palmidrol
Palmidrol may decrease the antihypertensive activities of Carvedilol.
Panobinostat
The serum concentration of Carvedilol can be increased when it is combined with Panobinostat.
Papaverine
The risk or severity of adverse effects can be increased when Papaverine is combined with Carvedilol.
Parecoxib
Parecoxib may decrease the antihypertensive activities of Carvedilol.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Carvedilol.
Pargyline
Pargyline may increase the hypotensive activities of Carvedilol.
Paroxetine
The metabolism of Carvedilol can be decreased when combined with Paroxetine.
Parthenolide
Parthenolide may decrease the antihypertensive activities of Carvedilol.
Pasireotide
Carvedilol may increase the bradycardic activities of Pasireotide.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Carvedilol.
Peginterferon Alfa-2b
The serum concentration of Carvedilol can be decreased when it is combined with Peginterferon alfa-2b.
Penbutolol
Penbutolol may increase the orthostatic hypotensive activities of Carvedilol.
Pentobarbital
The metabolism of Carvedilol can be increased when combined with Pentobarbital.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Carvedilol.
Perazine
Perazine may increase the hypotensive activities of Carvedilol.
Pergolide
Pergolide may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Periciazine
Carvedilol may increase the antihypertensive activities of Propericiazine.
Perindopril
Perindopril may increase the hypotensive activities of Carvedilol.
Perphenazine
Perphenazine may increase the hypotensive activities of Carvedilol.
Phendimetrazine
Carvedilol may decrease the vasoconstricting activities of Phendimetrazine.
Phenelzine
Phenelzine may increase the hypotensive activities of Carvedilol.
Phenobarbital
The metabolism of Carvedilol can be increased when combined with Phenobarbital.
Phenoxybenzamine
Carvedilol may increase the antihypertensive activities of Phenoxybenzamine.
Phentolamine
Carvedilol may increase the antihypertensive activities of Phentolamine.
Phentolamine Mesylate
Carvedilol may increase the antihypertensive activities of Phentolamine.
Phenylbutazone
Phenylbutazone may decrease the antihypertensive activities of Carvedilol.
Phenylephrine
Carvedilol may decrease the vasoconstricting activities of Phenylephrine.
Phenylpropanolamine
Carvedilol may decrease the vasoconstricting activities of Phenylpropanolamine.
Phenytoin
The metabolism of Carvedilol can be increased when combined with Phenytoin.
Physostigmine
Physostigmine may increase the bradycardic activities of Carvedilol.
Pilocarpine
The risk or severity of adverse effects can be increased when Carvedilol is combined with Pilocarpine.
Pimecrolimus
Pimecrolimus may decrease the antihypertensive activities of Carvedilol.
Pinacidil
Pinacidil may increase the hypotensive activities of Carvedilol.
Pinaverium
The risk or severity of hypotension can be increased when Carvedilol is combined with Pinaverium.
Pindolol
Pindolol may increase the orthostatic hypotensive activities of Carvedilol.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Carvedilol.
Pirbuterol
Carvedilol may decrease the vasoconstricting activities of Pirbuterol.
Pirfenidone
Pirfenidone may decrease the antihypertensive activities of Carvedilol.
Piroxicam
Piroxicam may decrease the antihypertensive activities of Carvedilol.
Piroxicam-Beta-Cyclodextrin
Piroxicam may decrease the antihypertensive activities of Carvedilol.
Pizotyline
Carvedilol may increase the antihypertensive activities of Pizotifen.
Polythiazide
Carvedilol may increase the hypotensive activities of Polythiazide.
Poractant alfa
Carvedilol may increase the bradycardic activities of Poractant alfa.
Posaconazole
The metabolism of Carvedilol can be decreased when combined with Posaconazole.
Practolol
Practolol may increase the orthostatic hypotensive activities of Carvedilol.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Carvedilol.
Prazosin
Prazosin may increase the antihypertensive activities of Carvedilol.
Prenylamine
The risk or severity of hypotension can be increased when Carvedilol is combined with Prenylamine.
Primaquine
The metabolism of Carvedilol can be decreased when combined with Primaquine.
Primidone
The metabolism of Carvedilol can be increased when combined with Primidone.
Procaine
Procaine may increase the hypotensive activities of Carvedilol.
Procarbazine
Procarbazine may increase the hypotensive activities of Carvedilol.
Procaterol
Carvedilol may decrease the vasoconstricting activities of Procaterol.
Prochlorperazine
Prochlorperazine may increase the hypotensive activities of Carvedilol.
Promazine
Carvedilol may increase the antihypertensive activities of Promazine.
Promethazine
Promethazine may increase the hypotensive activities of Carvedilol.
Propafenone
The serum concentration of Carvedilol can be increased when it is combined with Propafenone.
Propiomazine
Carvedilol may increase the antihypertensive activities of Propiomazine.
Propiverine
Carvedilol may increase the antihypertensive activities of Propiverine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Carvedilol.
Propranolol
Propranolol may increase the orthostatic hypotensive activities of Carvedilol.
Proscillaridin
Carvedilol may increase the bradycardic activities of Proscillaridin.
Pseudoephedrine
Pseudoephedrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Pyridostigmine
Pyridostigmine may increase the bradycardic activities of Carvedilol.
Pyridostigmine Bromide
Pyridostigmine may increase the bradycardic activities of Carvedilol.
Pyrimethamine
The serum concentration of Carvedilol can be increased when it is combined with Pyrimethamine.
Quetiapine
Carvedilol may increase the antihypertensive activities of Quetiapine.
Quetiapine fumarate
Carvedilol may increase the antihypertensive activities of Quetiapine.
Quinapril
Quinapril may increase the hypotensive activities of Carvedilol.
Quinidine
Carvedilol may increase the antihypertensive activities of Quinidine.
Quinine
The serum concentration of Carvedilol can be increased when it is combined with Quinine.
Racepinephrine
Carvedilol may increase the antihypertensive activities of Racepinephrine.
Ramipril
Ramipril may increase the hypotensive activities of Carvedilol.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Carvedilol.
Rasagiline
Rasagiline may increase the hypotensive activities of Carvedilol.
Regorafenib
Regorafenib may increase the bradycardic activities of Carvedilol.
Regular Insulin, Human
Carvedilol may increase the hypoglycemic activities of Insulin Human.
Remifentanil
Remifentanil may increase the bradycardic activities of Carvedilol.
Reproterol
Carvedilol may decrease the vasoconstricting activities of Reproterol.
Rescinnamine
Carvedilol may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Carvedilol.
Resveratrol
Resveratrol may decrease the antihypertensive activities of Carvedilol.
Rifabutin
The metabolism of Carvedilol can be increased when combined with Rifabutin.
Rifampin
The metabolism of Carvedilol can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Carvedilol can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Carvedilol.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Carvedilol.
Riociguat
Carvedilol may increase the hypotensive activities of Riociguat.
Risperidone
Carvedilol may increase the hypotensive activities of Risperidone.
Ritodrine
Carvedilol may decrease the vasoconstricting activities of Ritodrine.
Ritonavir
The metabolism of Carvedilol can be decreased when combined with Ritonavir.
Rituximab
Carvedilol may increase the hypotensive activities of Rituximab.
Rivastigmine
Carvedilol may increase the bradycardic activities of Rivastigmine.
Rofecoxib
Rofecoxib may decrease the antihypertensive activities of Carvedilol.
Rolapitant
The metabolism of Carvedilol can be decreased when combined with Rolapitant.
Ropinirole
Ropinirole may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Carvedilol.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Carvedilol.
Rucaparib
The serum concentration of Carvedilol can be increased when it is combined with Rucaparib.
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Carvedilol.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Carvedilol.
Salicylamide
Salicylamide may decrease the antihypertensive activities of Carvedilol.
Salicylic Acid
Salicylic acid may decrease the antihypertensive activities of Carvedilol.
Salmeterol
Carvedilol may decrease the vasoconstricting activities of Salmeterol.
Salsalate
Salsalate may decrease the antihypertensive activities of Carvedilol.
Saquinavir
The metabolism of Carvedilol can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Carvedilol can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Carvedilol can be decreased when used in combination with Sarilumab.
Secobarbital
The metabolism of Carvedilol can be increased when combined with Secobarbital.
Selegiline
Selegiline may increase the hypotensive activities of Carvedilol.
Selexipag
Carvedilol may increase the hypotensive activities of Selexipag.
Serratiopeptidase
Serrapeptase may decrease the antihypertensive activities of Carvedilol.
Sertraline
The metabolism of Carvedilol can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Carvedilol.
Sildenafil
The serum concentration of Carvedilol can be increased when it is combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Carvedilol.
Siltuximab
The serum concentration of Carvedilol can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Carvedilol can be increased when it is combined with Simeprevir.
Sorafenib
The serum concentration of Carvedilol can be increased when it is combined with Sorafenib.
Sotalol
Sotalol may increase the orthostatic hypotensive activities of Carvedilol.
Spirapril
Carvedilol may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Carvedilol.
ST. JOHN'S WORT EXTRACT
The serum concentration of Carvedilol can be decreased when it is combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Carvedilol.
Sufentanil
Sufentanil may increase the bradycardic activities of Carvedilol.
Sulfadiazine
The serum concentration of Carvedilol can be increased when it is combined with Sulfadiazine.
Sulfamethoxazole
The serum concentration of Carvedilol can be increased when it is combined with Sulfamethoxazole.
Sulfasalazine
Sulfasalazine may decrease the antihypertensive activities of Carvedilol.
Sulfisoxazole
The serum concentration of Carvedilol can be increased when it is combined with Sulfisoxazole.
Sulindac
Sulindac may decrease the antihypertensive activities of Carvedilol.
Suprofen
Suprofen may decrease the antihypertensive activities of Carvedilol.
Synephrine
Carvedilol may decrease the vasoconstricting activities of Synephrine.
Tacrine
Tacrine may increase the bradycardic activities of Carvedilol.
Tadalafil
Tadalafil may increase the hypotensive activities of Carvedilol.
Talinolol
Talinolol may increase the orthostatic hypotensive activities of Carvedilol.
Tamsulosin
Tamsulosin may increase the antihypertensive activities of Carvedilol.
Telaprevir
The metabolism of Carvedilol can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Carvedilol can be decreased when combined with Telithromycin.
Telmisartan
Telmisartan may increase the hypotensive activities of Carvedilol.
Tenofovir Disoproxil
The metabolism of Carvedilol can be decreased when combined with Tenofovir disoproxil.
Tenoxicam
Tenoxicam may decrease the antihypertensive activities of Carvedilol.
Terazosin
Carvedilol may increase the antihypertensive activities of Terazosin.
Terbinafine
The metabolism of Carvedilol can be decreased when combined with Terbinafine.
Terbutaline
Terbutaline may increase the orthostatic hypotensive activities of Carvedilol.
Terbutaline Sulfate
Terbutaline may increase the orthostatic hypotensive activities of Carvedilol.
Teriflunomide
The serum concentration of Carvedilol can be decreased when it is combined with Teriflunomide.
Terlipressin
Carvedilol may increase the hypotensive activities of Terlipressin.
Tertatolol
Tertatolol may increase the orthostatic hypotensive activities of Carvedilol.
Tetrahydrozoline
Carvedilol may decrease the vasoconstricting activities of Tetryzoline.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Carvedilol.
Theodrenaline
Carvedilol may increase the hypotensive activities of Theodrenaline.
Theophylline
Theophylline may increase the hypotensive activities of Carvedilol.
Theophylline anhydrous
Theophylline may increase the hypotensive activities of Carvedilol.
Thiamylal
The serum concentration of Carvedilol can be decreased when it is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Carvedilol.
Thiopental
The serum concentration of Carvedilol can be decreased when it is combined with Thiopental.
Thiopental Sodium
The serum concentration of Carvedilol can be decreased when it is combined with Thiopental.
Thioproperazine
Carvedilol may increase the antihypertensive activities of Thioproperazine.
Thioridazine
Carvedilol may increase the antihypertensive activities of Thioridazine.
Tiaprofenic Acid
Tiaprofenic acid may decrease the antihypertensive activities of Carvedilol.
Tibolone
Carvedilol may increase the hypotensive activities of Tibolone.
Ticagrelor
The serum concentration of Carvedilol can be increased when it is combined with Ticagrelor.
Ticlopidine
The serum concentration of Carvedilol can be increased when it is combined with Ticlopidine.
Timolol
Timolol may increase the orthostatic hypotensive activities of Carvedilol.
Timolol Anhydrous
Timolol may increase the orthostatic hypotensive activities of Carvedilol.
Tipranavir
The metabolism of Carvedilol can be decreased when combined with Tipranavir.
Tizanidine
Tizanidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Tocilizumab
The serum concentration of Carvedilol can be decreased when it is combined with Tocilizumab.
Tofacitinib
Tofacitinib may increase the bradycardic activities of Carvedilol.
Tolazamide
Carvedilol may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Carvedilol may increase the antihypertensive activities of Tolazoline.
Tolbutamide
The serum concentration of Carvedilol can be increased when it is combined with Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Carvedilol.
Tolfenamic Acid
The risk or severity of hypotension can be increased when Carvedilol is combined with Tolfenamic Acid.
Tolmetin
Tolmetin may decrease the antihypertensive activities of Carvedilol.
Toloxatone
Toloxatone may increase the hypotensive activities of Carvedilol.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Carvedilol.
Torsemide
Torasemide may increase the hypotensive activities of Carvedilol.
Trandolapril
Trandolapril may increase the hypotensive activities of Carvedilol.
Tranilast
The risk or severity of hypotension can be increased when Carvedilol is combined with Tranilast.
Tranylcypromine
The metabolism of Carvedilol can be decreased when combined with Tranylcypromine.
Travoprost
Travoprost may increase the hypotensive activities of Carvedilol.
Trazodone
Carvedilol may increase the antihypertensive activities of Trazodone.
Treprostinil
Treprostinil may increase the hypotensive activities of Carvedilol.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Carvedilol.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Carvedilol.
Tribenoside
Tribenoside may decrease the antihypertensive activities of Carvedilol.
Trichlormethiazide
Trichlormethiazide may increase the hypotensive activities of Carvedilol.
Trifluoperazine
Carvedilol may increase the antihypertensive activities of Trifluoperazine.
Triflupromazine
Triflupromazine may increase the hypotensive activities of Carvedilol.
Trimebutine
The risk or severity of hypotension can be increased when Carvedilol is combined with Trimebutine.
Trimeprazine
Alimemazine may increase the hypotensive activities of Carvedilol.
Trimethadione
The risk or severity of hypotension can be increased when Carvedilol is combined with Trimethadione.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Carvedilol.
Trimethoprim
The serum concentration of Carvedilol can be increased when it is combined with Trimethoprim.
Trimipramine
Carvedilol may increase the antihypertensive activities of Trimipramine.
Tubocurarine
Tubocurarine may increase the bradycardic activities of Carvedilol.
Tulobuterol
Carvedilol may decrease the vasoconstricting activities of Tulobuterol.
Tyrothricin
Tyrothricin may increase the bradycardic activities of Carvedilol.
UNOPROSTONE
Carvedilol may increase the hypotensive activities of Unoprostone.
Urapidil
Carvedilol may increase the antihypertensive activities of Urapidil.
Valdecoxib
Valdecoxib may decrease the antihypertensive activities of Carvedilol.
Valproate
The serum concentration of Carvedilol can be increased when it is combined with Valproic Acid.
Valproic Acid
The serum concentration of Carvedilol can be increased when it is combined with Valproic Acid.
Valsartan
The serum concentration of Carvedilol can be increased when it is combined with Valsartan.
Vardenafil
Vardenafil may increase the hypotensive activities of Carvedilol.
Varenicline
The risk or severity of adverse effects can be increased when Carvedilol is combined with Varenicline.
Vemurafenib
The serum concentration of Carvedilol can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Carvedilol can be decreased when combined with Venlafaxine.
Verapamil
Carvedilol may increase the antihypertensive activities of Verapamil.
Vilanterol
Carvedilol may decrease the vasoconstricting activities of Vilanterol.
Vincamine
Carvedilol may increase the hypotensive activities of Vincamine.
Vincristine
The excretion of Vincristine can be decreased when combined with Carvedilol.
Vinpocetine
Carvedilol may increase the hypotensive activities of Vinpocetine.
Voriconazole
The serum concentration of Carvedilol can be increased when it is combined with Voriconazole.
Xamoterol
Carvedilol may decrease the vasoconstricting activities of Xamoterol.
Xylazine
Xylazine may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Xylometazoline
Xylometazoline may increase the atrioventricular blocking (AV block) activities of Carvedilol.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Carvedilol.
Zafirlukast
The serum concentration of Carvedilol can be increased when it is combined with Zafirlukast.
Ziconotide
The risk or severity of hypotension can be increased when Carvedilol is combined with Ziconotide.
Zileuton
Zileuton may decrease the antihypertensive activities of Carvedilol.
Ziprasidone
Carvedilol may increase the antihypertensive activities of Ziprasidone.
Zofenopril
Carvedilol may increase the hypotensive activities of Zofenopril.
Zomepirac
Zomepirac may decrease the antihypertensive activities of Carvedilol.
Zonisamide
The risk or severity of hypotension can be increased when Carvedilol is combined with Zonisamide.
Zuclopenthixol
Carvedilol may increase the antihypertensive activities of Zuclopenthixol.
